The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year Pfizer revised its revenue expectations for 2025 and detailed its outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback